Labshake search
Citations for R&D Systems :
451 - 500 of 3760 citations for Testosterone 100 Ug Ml In Methylene Chloride 3 4 13C2 99%; 17 18O 98% since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Biophysics 2023Quote: ... and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ, R&D Systems) (Farnsworth et al. ...
-
bioRxiv - Neuroscience 2023Quote: ... and mouse epidermal growth factor (100 ng/ml) (R&D Systems, #2028-EG-200). Cells were plated in a six-well dish at a density of about 2 retinas per 10cm2 well ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Cell Biology 2024Quote: ... cells were stimulated with 100 ng/mL recombinant WNT3A (R&D Systems, 5036-WN) or WNT5A (R&D Systems ...
-
bioRxiv - Genomics 2024Quote: ... cells were also treated with or without TNFα (R&D systems, 100 ng/ml) at 48 h after transfection and harvested at 72 h after transfection (24 h after TNFα treatment).
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... penicillin-streptomycin) supplemented with 100 ng/mL EGF (R&D Systems, cat # 236-EG) and 100 ng/mL of BMP2 (R&D Systems ...
-
bioRxiv - Cancer Biology 2021Quote: ... MO) or using 50 μg/ml of LPS plus 50 ng/ml of mouse IL-4 from R&D Systems (Minneapolis, MN). After 4 days in complete RPMI media at 37°C ...
-
bioRxiv - Bioengineering 2021Quote: ... primary antibodies (E-cadherin, AF748, R&D Systems, 4 μg/mL; vimentin, ab92547, Abcam, 0.5 μg/mL; CD31, AF3628, R&D Systems, 10 μg/mL ...
-
bioRxiv - Immunology 2019Quote: ... Immature dendritic cells were prepared by treatment of monocytes with 500 U/ml human IL-4 and 800 U/ml human GM-CSF (R&D Systems) in CellGenix media for 6 days ...
-
bioRxiv - Immunology 2020Quote: ... in serum-free medium (5 x 106/4 ml of AIM-V) supplemented with M-CSF (50 ng/ml; R&D Systems) over 7 days followed by 18 h treatment with IFN-γ (20 ng/ml ...
-
bioRxiv - Immunology 2024Quote: ... Adherent cell were then cultured in RPMI supplemented with 10% heat-inactivated human serum and L-Glutamine and gentamycin as above (RPMI10%HuS) and 30 ng/ml GM-CSF (Immunex) and 10 ng/ml IL-4 (R&D Systems) for 5 days50 ...
-
bioRxiv - Microbiology 2020Quote: ... cells were pre-treated with IL-4 (200 U/ml) (R&D Systems, Minneapolis, MN) for 12h at 37°C and then stimulated and infected as above ...
-
bioRxiv - Cell Biology 2021Quote: ... and 4 mg/ml Collagen-I (Cultrex 3D rat tail collagen-I, R&D systems) on ice ...
-
bioRxiv - Cell Biology 2024Quote: ... and 50 ng/mL bone morphogenetic protein 4 (BMP4; 314-BP, R&D Systems, USA) on day 1 ...
-
bioRxiv - Microbiology 2023Quote: ... 100 µg/ml streptomycin and either 5 ng/ml granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems, Abingdon, UK) to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Immunology 2023Quote: ... and IL-17 in the culture supernatant was determined using ELISA kits from R&D systems DY485 ...
-
bioRxiv - Cell Biology 2019Quote: ... and expanded chondroprogenitor cells were re-suspended at 2.5 × 105 cells / mL in chondrogenic medium supplemented with 10 ng/ml human transforming growth factor beta 3 (TGF-β3; R&D Systems, Minneapolis, MN). Chondrogenic pellets were cultured at 37°C for 28 days ...
-
bioRxiv - Immunology 2023Quote: ... and 4 post PR8 infection with commercially available anti-FcγRIII antibody (100 µg/mouse; clone: 275003, R&D systems) and/or anti-FcγRIV antibody (200 µg/mouse ...
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Bioengineering 2024Quote: ... which was supplemented with 3 ng/mL human activin A (R&D Systems, Inc., Minneapolis, MN, USA), 1 ng/mL human bone morphogenetic protein 4 (Bmp4 ...
-
bioRxiv - Microbiology 2023Quote: ... ligand-loaded CD1d (0.25 ug per well) was bound onto Streptavidin-coated plates (R&D Systems #CP003). Plates were washed with PBS three times and then added 24.7 NKT cells (4 x 104∼105 per well ...
-
bioRxiv - Synthetic Biology 2021Quote: ... in a 1:1 ratio with 100 U mL-1 of IL-7 and 10U mL-1 IL-15 (R&D Systems) in tissue culture flasks ...
-
bioRxiv - Developmental Biology 2019Quote: ... and 100 ng/ml CHO-derived mouse R-spondin 1 or 5 ng/ml CHO-derived mouse R-spondin 2 (R&D System). The final concentration of Rspondins in the culture medium was initially tested in pilot experiments in order to add comparable amounts of bioactive ligands (bioactivity measured by TOPflash assays and organoid growth curves ...
-
bioRxiv - Immunology 2020Quote: ... and then re-suspended in 30 μL of media containing 10,000 units/mL of recombinant IFN-α2a or 100 units/mL of recombinant IFN-γ (R&D Systems). Antibodies against SiglecF ...
-
bioRxiv - Neuroscience 2023Quote: ... or bFGF (10 ng/mL) and diazepam (100 μM) (045-18901, Wako) or BMP4 (50 ng/mL) (5020-BP, R&D Systems) (quiescence medium ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Neuroscience 2021Quote: ... the supplements in the medium were replaced with FGF8 (100 ng/ml; R&D Systems). From day 11 ...
-
bioRxiv - Genomics 2022Quote: ... 15140122) supplemented with final 100 ng/ml Activin-A (R&D Systems, 338-AC-01M) and 1,4 µg/ml CHIR99021 (Stemgent ...
-
bioRxiv - Bioengineering 2023Quote: ... iASCs were prepared by pretreating ASCs with interferon γ (100 ng/ml; R&D Systems) in ASC culture medium for 24 hours ...
-
bioRxiv - Genomics 2023Quote: ... (Thermo Fisher Scientific)] medium supplemented with recombinant human/mouse/rat activin A (100 ng/mL; R&D Systems) for 18 hours ...
-
bioRxiv - Bioengineering 2022Quote: ... were coated with 4 μg ml-1 recombinant mouse IL-10 receptor alpha (R&D Systems) overnight at 4°C ...
-
bioRxiv - Molecular Biology 2022Quote: ... M2 macrophages were generated by stimulating Mϕ with 20 ng/ml IL-4 (R&D Systems) and 20 ng/ml IL-13 (R&D system ...
-
bioRxiv - Physiology 2024Quote: ... then stimulated with recombinant human IL-4 at 50 ng/mL (R&D Systems, Minneapolis, MN) in BEBM medium for 6 h or BEBM medium as control condition ...
-
bioRxiv - Immunology 2019Quote: ... then incubated overnight at 4°C in primary antibodies in 0.1% Triton X-100/PBS (rat anti-GP2, MBL, D278-3 at 1:500; sheep anti-SpiB, R&D Systems, AF7204 at 1:50 ...
-
bioRxiv - Neuroscience 2021Quote: ... Plates were washed 3 times with wash buffer and 100 ul of samples and standards were added (R&D Systems, UK). Plates were left to incubate at room temperature for 2 hours ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged by dissociation in 0.5 mM EDTA every 3-4 days and resuspended in Essential 8 Medium supplemented with Y-27632 dihydrochloride (10 μM; Cat.#1254; R&D Systems). For CRISPR-Cas9 editing ...
-
bioRxiv - Bioengineering 2024Quote: ... Hydrogels (n=3) were incubated for 4 hours in a solution of FBS-free DMEM supplemented with 10% Resazurin dye (AR002, R&D Systems) at 37°C ...
-
bioRxiv - Immunology 2021Quote: ... anti-IL-4 (1 μg/ml) R&D Systems Cat# MAB204) and anti-IFN-γ (1 μg/ml R&D Systems Cat#MAB-285). Differentiation of Th17 cells was confirmed by measuring IL-17 expression by quantitative real-time PCR ...
-
bioRxiv - Cell Biology 2023Quote: ... alone or sequentially with 100 μL/mL polylysine and 400 ng/mL netrin-1 (R&D systems, catalog number 6419-N1-025/CF), and cultured in Neurobasal Medium (Thermo Fisher Scientific ...
-
bioRxiv - Cell Biology 2023Quote: ... after which the cells were exposed for 3 days to 200 ng/ml FGF-9 (R&D systems) and 1μg/mL heparin (Sigma Aldrich ...
-
bioRxiv - Developmental Biology 2024Quote: ... and incubated with rabbit active Caspase-3 (5 μg/ml, AF835-SP, R&D systems, Inc., Minneapolis, MN), rabbit cleaved Caspase-9 (1:50 ...
-
bioRxiv - Neuroscience 2020Quote: ... Glass coverslips were coated with alternating stripes (IgG or Sema7a 100 μg/ml, R&D Systems), which were then covered by laminin (20 μg/ml) ...
-
bioRxiv - Cell Biology 2020Quote: ... 5μM Y-27632 and 100 ng/ml recombinant mouse Noggin (R&D Systems, 1967-NG-025)) ...
-
bioRxiv - Immunology 2023Quote: ... CTL medium containing 100 IU/ml human IL-2 (R&D Systems, 202-IL-010/CF) was added to the plates and the expansion of T cells continued ...
-
bioRxiv - Genetics 2023Quote: ... in presence or absence of IFN γ (R&D Systems, 485-MI-100, 10 ng/ml). On day 2 of reprogramming ...
-
bioRxiv - Genetics 2023Quote: ... in presence or absence of IFN γ (R&D Systems, 485-MI-100, 10 ng/ml) for the first 5 days ...
-
bioRxiv - Cell Biology 2023Quote: ... starved overnight and exposed to 1.5 ng/ml of TFGβ (#100-B-001, R&D Systems) for 6 and 24 hours ...